171 related articles for article (PubMed ID: 3172841)
21. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
[TBL] [Abstract][Full Text] [Related]
23. Clinical stage of chronic granulocytic leukaemia and BCR breakpoint location in South-East Asian patients.
Dyck JA; Bosco JJ
Br J Haematol; 1989 May; 72(1):64-7. PubMed ID: 2736243
[TBL] [Abstract][Full Text] [Related]
24. Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease.
Tien HF; Wang CH; Chen YC; Shen MC; Wu HS; Lee FY; Chuang SM; Liu CH
Br J Haematol; 1990 Aug; 75(4):469-75. PubMed ID: 2206998
[TBL] [Abstract][Full Text] [Related]
25. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.
Suryanarayan K; Hunger SP; Kohler S; Carroll AJ; Crist W; Link MP; Cleary ML
Blood; 1991 Jan; 77(2):324-30. PubMed ID: 1985699
[TBL] [Abstract][Full Text] [Related]
26. Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies.
Saglio G; Guerrasio A; Tassinari A; Ponzetto C; Zaccaria A; Testoni P; Celso B; Rege Cambrin G; Serra A; Pegoraro L
Blood; 1988 Oct; 72(4):1203-8. PubMed ID: 3167203
[TBL] [Abstract][Full Text] [Related]
27. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
28. CML patients in blast crisis have breakpoints localized to a specific region of the BCR.
Schaefer-Rego K; Dudek H; Popenoe D; Arlin Z; Mears JG; Bank A; Leibowitz D
Blood; 1987 Aug; 70(2):448-55. PubMed ID: 3038213
[TBL] [Abstract][Full Text] [Related]
29. Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival.
Selleri L; Emilia G; Temperani P; Grassilli E; Zucchini P; Tagliafico E; Bonati A; Venezia L; Ferrari S; Torelli U
Leukemia; 1989 Jul; 3(7):538-42. PubMed ID: 2733455
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
[TBL] [Abstract][Full Text] [Related]
31. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
32. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
33. Molecular abnormalities of bcr gene in some Indian patients with chronic myeloid leukaemia.
Chandrasekaran R; Murthy PB
Indian J Med Res; 1996 May; 103():267-71. PubMed ID: 8707363
[TBL] [Abstract][Full Text] [Related]
34. Chromosome abnormalities in CML.
Hagemeijer A
Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
[TBL] [Abstract][Full Text] [Related]
35. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
36. Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
Chin YM; Bosco JJ; Koh CL
Med J Malaysia; 1992 Jun; 47(2):110-3. PubMed ID: 1494330
[TBL] [Abstract][Full Text] [Related]
37. The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.
Verschraegen CF; Kantarjian HM; Hirsch-Ginsberg C; Lee MS; O'Brien S; Rios MB; Stass SA; Keating M; Talpaz M
Cancer; 1995 Sep; 76(6):992-7. PubMed ID: 8625225
[TBL] [Abstract][Full Text] [Related]
38. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
39. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the translocation breakpoint in a patient with Philadelphia positive, bcr negative acute lymphoblastic leukaemia.
van der Feltz MJ; Shivji MK; Grosveld G; Wiedemann LM
Oncogene; 1988 Aug; 3(2):215-9. PubMed ID: 3166123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
